AI assistant
Sending…
Aclarion, Inc. — Director's Dealing 2022
Apr 25, 2022
35434_dirs_2022-04-25_343353a1-3b43-4f8d-a02c-a5cb2041f3dd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aclarion, Inc. (ACON)
CIK: 0001635077
Period of Report: 2022-04-22
Reporting Person: Bond Ryan (Chief Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-22 | Common Stock | P | 20000 | $2.80 | Acquired | 20000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-04-22 | Warrants for Common Stock (right to buy) | $4.35 | P | 21000 | Acquired | 2027-04-21 | Common Stock (21000) | Direct |
Footnotes
F1: The Reporting Person purchased common stock and warrants for common stock on the public market on 4/22/2022, which was the first day of trading after the Company's initial public offering ("IPO"). Each common stock warrant has an exercise price of $4.35 per common share, and may be exercised at any time up to five years from the date of issue.
More from Aclarion, Inc.
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Jan 13
Regulatory Filings
2026
Jan 9
Regulatory Filings
2026
Jan 9
Director's Dealing
2025
Dec 1
Interim / Quarterly Report
2025
Nov 12
Regulatory Filings
2025
Oct 14
Regulatory Filings
2025
Oct 14
Director's Dealing
2025
Sep 3